Floatz logo

TAURURSODIOL

Senile Cardiac Amyloidosis

Brigham and Women's HospitalSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Senile Cardiac Amyloidosis cohort.

Asset / SponsorPhaseRating
Doxycycline
Brigham and Women's Hospital
Phase 1/2CCC

Same molecule, other indications

TAURURSODIOL is also rated in:

amyotrophic lateral sclerosisDormant
BBB
Indicative ·
74 / 100
View asset →
primary biliary cholangitisDormant
BB
Indicative ·
64 / 100
View asset →
wild type ATTR amyloidosisDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →